High efficacy of eight weeks of ledipasvir/sofosbuvir (LDV/SOF) in African Americans with hepatitis C virus genotype 1 infection in a real-world clinic setting.
High efficacy of eight weeks of ledipasvir/sofosbuvir (LDV/SOF) in African Americans with hepatitis C virus genotype 1 infection in a real-world clinic setting.
- 2018
Medicine/Infectious Diseases
Poster presented at
Medicine/Infectious Diseases
Poster presented at